Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine alone versus ropivacaine + morphine + betamethasone for analgesia in total hip arthroplasty
ChiCTR1800018377Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine, morphine and betamethasone in postoperative pain, sponsored by West China Hospital of Sichuan University. Primary endpoints: Pain, Function outcomes and 2 more. Started Sep 2018; status: recruiting.
02
Drugs
ropivacainemorphinebetamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800018377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018377.